Protein-engineering platform that targets therapeutic proteins to red blood cell precursors and mature red blood cells to selectively stimulate erythropoiesis while extending plasma half-life and reducing immune detection. Recombinant protein production and assay capabilities plus contract engineering services for design and optimization of therapeutic protein sequences, antibody/linker elements, DNA coding sequences, and expression constructs.